Information Collection Request Submitted to OMB for Review and Approval; Comment Request; NESHAP for Pharmaceuticals Production (Renewal), 28595-28596 [2021-11184]

Download as PDF Federal Register / Vol. 86, No. 101 / Thursday, May 27, 2021 / Notices Any person desiring to intervene or protest in any of the above proceedings must file in accordance with Rules 211 and 214 of the Commission’s Regulations (18 CFR 385.211 and 385.214) on or before 5:00 p.m. Eastern time on the specified comment date. Protests may be considered, but intervention is necessary to become a party to the proceeding. eFiling is encouraged. More detailed information relating to filing requirements, interventions, protests, service, and qualifying facilities filings can be found at: https://www.ferc.gov/ docs-filing/efiling/filing-req.pdf. For other information, call (866) 208–3676 (toll free). For TTY, call (202) 502–8659. Dated: May 21, 2021. Debbie-Anne A. Reese, Deputy Secretary. [FR Doc. 2021–11238 Filed 5–26–21; 8:45 am] BILLING CODE 6717–01–P DEPARTMENT OF ENERGY Federal Energy Regulatory Commission [Docket No. AD21–13–000] jbell on DSKJLSW7X2PROD with NOTICES Climate Change, Extreme Weather, and Electric System Reliability; Supplemental Notice of Technical Conference As announced in the Notice of Technical Conference issued in this proceeding on March 5, 2021, Federal Energy Regulatory Commission (Commission) staff will convene a technical conference to discuss issues surrounding the threat to electric system reliability posed by climate change and extreme weather events. The conference will be held on Tuesday, June 1, 2021 and Wednesday June 2, 2021, from approximately 1:00 p.m. to 6:00 p.m. Eastern Time each day. The conference will be held virtually via WebEx. Commissioners may attend and participate. We note that discussions at the conference may involve issues raised in proceedings that are currently pending before the Commission. These proceedings include, but are not limited to: California Independent System Operator Corp., Docket No. ER21–1536–000 California Independent System Operator Corp., Docket No. ER21–1551–000 California Independent System Operator Corp., Docket No. ER21–1790–000 CAlifornians for Renewable Energy v. California Independent System Operator Corp., Docket No. EL20–69– 001 VerDate Sep<11>2014 17:29 May 26, 2021 Jkt 253001 Central Hudson Gas & Elec. Corp., et al. v. New York Independent System Operator, Inc., Docket No. EL21–66– 000 Complaint of Michael Mabee, Docket No. EL21–54–000 Duke Energy Carolinas, LLC, et al. , Docket No. ER21–1579–000 George Berka v. Andrew Cuomo, et al., Docket No. EL21–61–000 New York Independent System Operator, Inc., Docket Nos. ER21– 502–002, ER21–502–003 New York Independent System Operator, Inc., Docket Nos. ER21– 1018–000, ER21–1018–001 New York Transmission Owners, Docket No. ER21–1647–000 NV Energy v. California Independent System Operator Corp., Docket No. EL21–74–000 PJM Interconnection, L.L.C., Docket No. ER21–278–001 PJM Interconnection, L.L.C., Docket Nos. EL19–100–000, ER20–584–000 PJM Interconnection, L.L.C., Docket No. ER21–1635–000 Attached to this Supplemental Notice is an agenda for the technical conference, which includes the final conference program and expected speakers. The conference will be open for the public to attend virtually. Information on the technical conference will also be posted on the Calendar of Events on the Commission’s website, https://www.ferc.gov, prior to the event. The conference will be transcribed. Transcripts of the conference will be available for a fee from Ace-Federal Reporters, Inc. (202–347–3700). For more information about this technical conference, please contact Rahim Amerkhail, 202–502–8266, rahim.amerkhail@ferc.gov for technical questions or Sarah McKinley, 202–502– 8368, sarah.mckinley@ferc.gov for logistical issues. Dated: May 21, 2021. Debbie-Anne A. Reese, Deputy Secretary. [FR Doc. 2021–11240 Filed 5–26–21; 8:45 am] BILLING CODE 6717–01–P ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–OECA–2013–0349; FRL–10024– 52–OMS] Information Collection Request Submitted to OMB for Review and Approval; Comment Request; NESHAP for Pharmaceuticals Production (Renewal) Environmental Protection Agency (EPA). AGENCY: PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 ACTION: 28595 Notice. The Environmental Protection Agency has submitted an information collection request (ICR), NESHAP for Pharmaceuticals Production, to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act. This is a proposed extension of the ICR, which is currently approved through July 31, 2021. Public comments were previously requested, via the Federal Register, on May 12, 2020 during a 60-day comment period. This notice allows for an additional 30 days for public comments. A fuller description of the ICR is given below, including its estimated burden and cost to the public. An Agency may neither conduct nor sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. DATES: Additional comments may be submitted on or before June 28, 2021. ADDRESSES: Submit your comments to EPA, referencing Docket ID Number EPA–HQ–OECA–2013–0349, online using www.regulations.gov (our preferred method), or by mail to: EPA Docket Center, Environmental Protection Agency, Mail Code 28221T, 1200 Pennsylvania Ave. NW, Washington, DC 20460. EPA’s policy is that all comments received will be included in the public docket without change including any personal information provided, unless the comment includes profanity, threats, information claimed to be Confidential Business Information (CBI), or other information whose disclosure is restricted by statute. Submit written comments and recommendations to OMB for the proposed information collection within 30 days of publication of this notice to www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: Patrick Yellin, Monitoring, Assistance, and Media Programs Division, Office of Compliance, Mail Code 2227A, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460; telephone number: (202) 564– 2970; fax number: (202) 564–0050; email address: yellin.patrick@epa.gov. SUPPLEMENTARY INFORMATION: Supporting documents, which explain in detail the information that the EPA will be collecting, are available in the public docket for this ICR. The docket SUMMARY: E:\FR\FM\27MYN1.SGM 27MYN1 jbell on DSKJLSW7X2PROD with NOTICES 28596 Federal Register / Vol. 86, No. 101 / Thursday, May 27, 2021 / Notices can be viewed online at www.regulations.gov, or in person, at the EPA Docket Center, WJC West, Room 3334, 1301 Constitution Ave. NW, Washington, DC. The telephone number for the Docket Center is 202–566–1744. For additional information about EPA’s public docket, visit: https:// www.epa.gov/dockets. Abstract: The NESHAP for Pharmaceuticals Production were proposed on April 2, 1997, and promulgated on September 21, 1998, and amended on both April 21, 2011 and February 27, 2014. In general, all NESHAP standards require initial notifications, performance tests, and periodic reports. Owners or operators are also required to maintain records of the occurrence and duration of any malfunctions in the operation of an affected facility, or any period during which the monitoring system is inoperative. These notifications, reports, and records are essential in determining compliance and, in general, are required of all sources subject to NESHAP. This information is used by the Agency to identify sources subject to these standards to ensure that the maximum achievable control technologies are being applied. Semiannual summary reports are also required. Form Numbers: None. Respondents/affected entities: Pharmaceutical manufacturing operations. Respondent’s obligation to respond: Mandatory (40 CFR part 63, subpart GGG). Estimated number of respondents: 27 (total). Frequency of response: Initially, occasionally, quarterly and semiannually. Total estimated burden: 44,300 hours (per year). Burden is defined at 5 CFR 1320.3(b). Total estimated cost: $5,300,000 (per year), which includes $112,000 in annualized capital/startup and/or operation & maintenance costs. Changes in the Estimates: There is no change in burden from the mostrecently approved ICR as currently identified in the OMB Inventory of Approved Burdens. This is due to two considerations: (1) The regulations have not changed over the past three years and are not anticipated to change over the next three years; and (2) the growth rate for this industry is very low or nonexistent, so there is no significant change in the overall burden. Since there are no changes in the regulatory requirements and there is no significant industry growth, there are also no changes in the capital/startup or VerDate Sep<11>2014 17:29 May 26, 2021 Jkt 253001 operation and maintenance (O&M) costs. Courtney Kerwin, Director, Regulatory Support Division. [FR Doc. 2021–11184 Filed 5–26–21; 8:45 am] BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION AGENCY [EPA–OW–2013–0610; FRL–10024–55–OMS] Information Collection Request Submitted to OMB for Review and Approval; Comment Request; Clean Water Act Section 404 State-Assumed Programs (Renewal) Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: The Environmental Protection Agency (EPA) has submitted an information collection request (ICR), Clean Water Act Section 404 StateAssumed Programs (EPA ICR Number 0220.14, OMB Control Number 2040– 0168) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act. This is a proposed extension of the ICR, which is currently approved through July 31, 2021. Public comments were previously requested, via Federal Register during a 60-day comment period. This notice allows for an additional 30 days for public comments. A fuller description of the ICR is given below, including its estimated burden and cost to the public. An agency may not conduct, or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. DATES: Comments must be received on or before June 28, 2021. ADDRESSES: Submit your comments to EPA, referencing Docket ID EPA–OW– 2013–0610, online using www.regulations.gov (our preferred method), or by mail to: EPA Docket Center, Environmental Protection Agency, Mail Code 28221T, 1200 Pennsylvania Ave. NW, Washington, DC 20460. EPA’s policy is that all comments received will be included in the public docket without change including any personal information provided, unless the comment includes profanity, threats, information claimed to be Confidential Business Information (CBI), or other information whose disclosure is restricted by statute. Submit written comments and recommendations to OMB for the proposed information collection within SUMMARY: PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 30 days of publication of this notice to www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: Dolores Wesson, Oceans, Communities, and Wetlands Division, Environmental Protection Agency, 1200 Pennsylvania Ave. NW (4504T), Washington, DC 20460; telephone number: 202–566– 2755; email: wesson.dolores@epa.gov. SUPPLEMENTARY INFORMATION: Supporting documents, which explain in detail the information that EPA will be collecting, are available in the public docket for this ICR. The docket can be viewed online at www.regulations.gov or in person at the EPA Docket Center, WJC West, Room 3334, 1301 Constitution Ave. NW, Washington, DC The telephone number for the Docket Center is 202–566–1744. Abstract: Section 404(g) of the Federal Water Pollution Control Act (FWPCA/ CWA) authorizes States and Tribes to assume the section 404 permit program for discharges of dredged or fill material into certain waters of the United States. This ICR covers the collection of information EPA needs to perform its program approval and oversight responsibilities and the State or Tribe needs to implement its program. Request to assume CWA section 404 permit program. States and Tribes must demonstrate that they meet the statutory and regulatory requirements at 40 CFR part 233 for an approvable program. Specified information and documents must be submitted by the State or Tribe to EPA to request assumption and must be sufficient to enable EPA to undertake an analysis of the State or tribal program. The information contained in the assumption request submission is provided to the other involved federal agencies (e.g., U.S. Army Corps of Engineers, U.S. Fish and Wildlife Service, and National Marine Fisheries Service) and to the public for review and comment. Permit application information. States and Tribes with assumed programs must be able to issue permits that assure compliance with all applicable statutory and regulatory requirements, including CWA section 404(b)(1) Guidelines. Sufficient information must be provided in the application so that States or Tribes and federal agencies reviewing the permit can evaluate, avoid, minimize, and compensate for any anticipated impacts resulting from the proposed project. EPA’s assumption regulations at 40 CFR 233.30 establish E:\FR\FM\27MYN1.SGM 27MYN1

Agencies

[Federal Register Volume 86, Number 101 (Thursday, May 27, 2021)]
[Notices]
[Pages 28595-28596]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11184]


=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OECA-2013-0349; FRL-10024-52-OMS]


Information Collection Request Submitted to OMB for Review and 
Approval; Comment Request; NESHAP for Pharmaceuticals Production 
(Renewal)

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency has submitted an 
information collection request (ICR), NESHAP for Pharmaceuticals 
Production, to the Office of Management and Budget (OMB) for review and 
approval in accordance with the Paperwork Reduction Act. This is a 
proposed extension of the ICR, which is currently approved through July 
31, 2021. Public comments were previously requested, via the Federal 
Register, on May 12, 2020 during a 60-day comment period. This notice 
allows for an additional 30 days for public comments. A fuller 
description of the ICR is given below, including its estimated burden 
and cost to the public. An Agency may neither conduct nor sponsor, and 
a person is not required to respond to, a collection of information 
unless it displays a currently valid OMB control number.

DATES: Additional comments may be submitted on or before June 28, 2021.

ADDRESSES: Submit your comments to EPA, referencing Docket ID Number 
EPA-HQ-OECA-2013-0349, online using www.regulations.gov (our preferred 
method), or by mail to: EPA Docket Center, Environmental Protection 
Agency, Mail Code 28221T, 1200 Pennsylvania Ave. NW, Washington, DC 
20460. EPA's policy is that all comments received will be included in 
the public docket without change including any personal information 
provided, unless the comment includes profanity, threats, information 
claimed to be Confidential Business Information (CBI), or other 
information whose disclosure is restricted by statute.
    Submit written comments and recommendations to OMB for the proposed 
information collection within 30 days of publication of this notice to 
www.reginfo.gov/public/do/PRAMain. Find this particular information 
collection by selecting ``Currently under 30-day Review--Open for 
Public Comments'' or by using the search function.

FOR FURTHER INFORMATION CONTACT: Patrick Yellin, Monitoring, 
Assistance, and Media Programs Division, Office of Compliance, Mail 
Code 2227A, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, 
Washington, DC 20460; telephone number: (202) 564-2970; fax number: 
(202) 564-0050; email address: [email protected].

SUPPLEMENTARY INFORMATION: Supporting documents, which explain in 
detail the information that the EPA will be collecting, are available 
in the public docket for this ICR. The docket

[[Page 28596]]

can be viewed online at www.regulations.gov, or in person, at the EPA 
Docket Center, WJC West, Room 3334, 1301 Constitution Ave. NW, 
Washington, DC. The telephone number for the Docket Center is 202-566-
1744. For additional information about EPA's public docket, visit: 
https://www.epa.gov/dockets.
    Abstract: The NESHAP for Pharmaceuticals Production were proposed 
on April 2, 1997, and promulgated on September 21, 1998, and amended on 
both April 21, 2011 and February 27, 2014. In general, all NESHAP 
standards require initial notifications, performance tests, and 
periodic reports. Owners or operators are also required to maintain 
records of the occurrence and duration of any malfunctions in the 
operation of an affected facility, or any period during which the 
monitoring system is inoperative. These notifications, reports, and 
records are essential in determining compliance and, in general, are 
required of all sources subject to NESHAP. This information is used by 
the Agency to identify sources subject to these standards to ensure 
that the maximum achievable control technologies are being applied. 
Semiannual summary reports are also required.
    Form Numbers: None.
    Respondents/affected entities: Pharmaceutical manufacturing 
operations.
    Respondent's obligation to respond: Mandatory (40 CFR part 63, 
subpart GGG).
    Estimated number of respondents: 27 (total).
    Frequency of response: Initially, occasionally, quarterly and 
semiannually.
    Total estimated burden: 44,300 hours (per year). Burden is defined 
at 5 CFR 1320.3(b).
    Total estimated cost: $5,300,000 (per year), which includes 
$112,000 in annualized capital/startup and/or operation & maintenance 
costs.
    Changes in the Estimates: There is no change in burden from the 
most-recently approved ICR as currently identified in the OMB Inventory 
of Approved Burdens. This is due to two considerations: (1) The 
regulations have not changed over the past three years and are not 
anticipated to change over the next three years; and (2) the growth 
rate for this industry is very low or non-existent, so there is no 
significant change in the overall burden. Since there are no changes in 
the regulatory requirements and there is no significant industry 
growth, there are also no changes in the capital/startup or operation 
and maintenance (O&M) costs.

Courtney Kerwin,
Director, Regulatory Support Division.
[FR Doc. 2021-11184 Filed 5-26-21; 8:45 am]
BILLING CODE 6560-50-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.